Literature DB >> 29888760

Evaluating the Analgesic Effect of the GLS Inhibitor 6-Diazo-5-Oxo-L-Norleucine in Vivo.

Heith A Crosby1, Kenneth E Miller1.   

Abstract

Glutamate is an excitatory neurotransmitter, produced by its synthetic enzyme, glutaminase (GLS), and packaged by vesicular transporters (VGluT2) into synaptic vesicles. Primary sensory peripheral nerve and spinal synaptic terminals release glutamate during nociceptive (pain) signaling. In post-incisional and inflammation models in rats, GLS and VGluT2 production is elevated in dorsal root ganglion neuronal cell bodies and transported to peripheral and spinal terminals for increased glutamate synthesis and release. 6-Diazo-5-oxo-l-norleucine (DON) is a GLS inhibitor that produces long lasting pain relief when applied to the inflamed paw of arthritic rats, but its effect in a post-incisional model has not been evaluated. In this study, we examined the analgesic efficacy of DON in a surgical incision model by measuring thermal latency and mechanical allodynia. Following behavioral evaluation, we examined the skin for VGluT2, GLS and glutamate immunoreactivity (ir). Our findings revealed that VGluT2-ir is elevated in the stratum lucidum by approximately 19%, 64 hours post-surgical incision and attenuated by approximately 5.4% after the administration of DON. During that same period GLS-ir was elevated in dermal nerve fibers by 52% and was attenuated by approximately 27.9% after the application of DON. Additionally, glutamate-ir was elevated in epidermal nerve fibers by 35% after incision and attenuated by approximately 23% after the administration of DON. Behavioral testing 24 and 48 hours after a single local administration of DON showed five out of six animals having an analgesic response to mechanical allodynia, but not to thermal hyperalgesia. Following a surgical incision, the area of injury shows increased VGluT2-, GLS-, glutamate-ir, mechanical allodynia and no change in thermal latency. After the application of the GLS inhibitor, DON, nerve fiber of the skin showed decreased VGluT2, GLS, and glutamate-ir. Furthermore, post-incision DON treated animals exhibited decreased mechanical allodynia with no change in thermal latency when compared to control animals.

Entities:  

Keywords:  6-diazo-5-oxo-l-norleucine; DON; DRG; GLS; Glutamate; Glutaminase; Incision; Post-surgical pain; Sprague-Dawley rats; VGluT2

Year:  2016        PMID: 29888760      PMCID: PMC5993434          DOI: 10.15406/ppij.2015.03.00055

Source DB:  PubMed          Journal:  Pharm Pharmacol Int J        ISSN: 2379-6367


  32 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  Interrelated effects of calcium and sulfhydryl reagents on renal phosphate-activated glutaminase.

Authors:  E Kvamme; B Roberg; L Johansen; I A Torgner
Journal:  Contrib Nephrol       Date:  1988       Impact factor: 1.580

3.  Electrophysiological differences between nociceptive and non-nociceptive dorsal root ganglion neurones in the rat in vivo.

Authors:  X Fang; S McMullan; S N Lawson; L Djouhri
Journal:  J Physiol       Date:  2005-04-14       Impact factor: 5.182

4.  Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats.

Authors:  N B Lawand; W D Willis; K N Westlund
Journal:  Eur J Pharmacol       Date:  1997-04-18       Impact factor: 4.432

5.  Efficient analysis of experimental observations.

Authors:  W J Dixon
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

6.  AMPA glutamatergic receptor-immunoreactive subunits are expressed in lumbosacral neurons of the spinal cord and neurons of the dorsal root and pelvic ganglia controlling pelvic functions in the rat.

Authors:  I Chambille; O Rampin
Journal:  Brain Res       Date:  2002-04-12       Impact factor: 3.252

7.  Glutaminase inhibition and the release of neurotransmitter glutamate from synaptosomes.

Authors:  H F Bradford; H K Ward; P Foley
Journal:  Brain Res       Date:  1989-01-02       Impact factor: 3.252

8.  Peripheral inhibition of glutaminase reduces carrageenan-induced Fos expression in the superficial dorsal horn of the rat.

Authors:  Ernest M Hoffman; Kenneth E Miller
Journal:  Neurosci Lett       Date:  2010-02-02       Impact factor: 3.046

9.  Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase.

Authors:  F Conti; A Minelli
Journal:  J Histochem Cytochem       Date:  1994-06       Impact factor: 2.479

Review 10.  Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states.

Authors:  Yuan-Xiang Tao; Jianguo Gu; Robert L Stephens
Journal:  Mol Pain       Date:  2005-10-21       Impact factor: 3.395

View more
  1 in total

1.  Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.

Authors:  Michael T Nedelcovych; Boe-Hyun Kim; Xiaolei Zhu; Lyndah E Lovell; Arena A Manning; Jennifer Kelschenbach; Eran Hadas; Wei Chao; Eva Prchalová; Ranjeet P Dash; Ying Wu; Jesse Alt; Ajit G Thomas; Rana Rais; Atsushi Kamiya; David J Volsky; Barbara S Slusher
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-17       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.